Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: a Blueprint for Transforming Prevention, Care, Education and Research. Washington, DC: The National Academies Press; 2011. http://books.nap.edu/openbook.php?record_id=13172&page=1. Accessed November 16, 2014.
The National Alliance for Model State Drug Laws and The National Safety Council. Prescription Drug Abuse, Addiction and Diversion: Overview of State Legislative and Policy Initiatives, Part 3: Prescribing of Controlled Substances for Non-Cancer Pain. http://www.namsdl.org/library/7176E80B-1C23-D4F9-745A3D08D1C82161/. Published October 2013. Accessed December 14, 2014.
Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147(7):492-514.
Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: volume 1: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2011. http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.pdf Published September 2011. Accessed November 14, 2014.
U.S. Department of Health and Human Services, U.S. Food and Drug Administration, and Center for Drug Evaluation and Research (CDER). Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies. U.S. Food and Drug Administration. http://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126833.pdf. Published December 2002. Accessed November 16, 2014.
National Institute on Drug Abuse. (2011). Topics in Brief: Prescription Drug Abuse. Accessed December 5, 2014.
Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444-59.
Data on file: Versta Research. Survey on Pain Matters, Report of Findings from the Chronic Pain and Abuse Deterrence Technology Surveys of Patients and Healthcare Professionals. 2015.
K. Dijkstra, M.E. Pietrse, A. Th. H. Pruyn. Individual differences in reactions towards color in simulated healthcare environments: The role of stimulus screening ability. Journal of Environmental Psychology. 28(3):268–277. Published September 2008.
Morton Walker. The Power of Color. New York, Avery Publishing Group. 1991; 50-52.
Sibel S. Dazkir, Marilyn A. Read. Furniture Forms and Their Influence on Our Emotional Responses Toward Interior Environments. Oregon State University. 2011; 1. http://eab.sagepub.com/content/44/5/722.
Dr. Zackary Berger, Talking to Your Doctor: A Patient's Guide to Communication in the Exam Room and Beyond. Rowman & Littlefield Publishers; 1 edition. 2013
Rabinowitz, I, Tamir, R, Reis, A. Length of patient's monologue, rate of completion, and relation to other components of the clinical encounter. British Medical Journal. 2004;501-502.
Beckman HB, Frankel RM. The effect of physician behavior on the collection of data. Annals of Internal Medicine, 1984;692-696.
Centers for Disease Control and Prevention. Injection Safety: Risks of Healthcare-associated Infections from Drug Diversion. Centers for Disease Control and Prevention. http://www.cdc.gov/injectionsafety/drugdiversion/. Published June 2014. Accessed November 19, 2015
You are about to leave the PainMatters.com website and enter a website operated by a third party. Teva Pharmaceuticals is not responsible for and does not control the content contained on any third-party website linked to PainMatters.com.